Fig. 1From: A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinomaThe research workflow. After the patient was enrolled, radiomics and hematology analyses were conducted separately, using LASSO regression to reduce the dimensionality of features. Then, radScore and hemScore were calculated, and they were combined with independent factors influencing pCR to develop a nomogram. Evaluated the predictive ability of three models, including ROC curve, calibration curve, DCA, etc.Back to article page